The global burden of chronic kidney failure (end stage renal disease) is primarily driven by the current parallel rise in the prevalence of diabetes and high blood pressure (hypertension). Asia, which has more than 60% of the world’s population, is at the forefront of this global epidemic of diabetes and kidney disease. Juliana Chan offers some background on the current status of care for kidney disease
and reports on the NephroAsia 2004 meeting in Singapore.
Singapore, NephroAsia, kidney, China, Asia, putative genes